Information
-
Trademark
-
78285532
-
Serial Number
78285532
-
Registration Number
2943640
-
International Classifications
-
Filing Date
August 11, 2003
21 years ago
-
Registration Date
April 26, 2005
19 years ago
-
Transaction Date
November 06, 2012
12 years ago
-
Status Date
September 28, 2012
12 years ago
-
Published for Opposition Date
February 01, 2005
19 years ago
-
Location Date
April 26, 2005
19 years ago
-
Status Code
710
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
SUAREZ, MARIA VICTORIA
-
Attorney Docket Number
21573.Avidex
Attorney Name
Purvi J. Patel
Law Office Assigned Location Code
L20
-
Owners
Mark Drawing Code
1000
Mark Identification
RHUDEX
Case File Statements
- GS0051: Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics
- GS0101: Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors, syringes, pre-filled vials containing pharmaceuticals and bioceuticals, namely small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases
- GS0421: Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property namely, trademarks and patents in the field of biotechnology
Case File Event Statements
-
9/28/2012 - 12 years ago
16 - CANCELLED SEC. 8 (6-YR)
Type: C8..
-
12/17/2008 - 16 years ago
15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
12/17/2008 - 16 years ago
14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
9/19/2007 - 17 years ago
13 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN
-
4/26/2005 - 19 years ago
12 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
2/1/2005 - 19 years ago
11 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
1/12/2005 - 20 years ago
10 - NOTICE OF PUBLICATION
Type: NPUB
-
11/30/2004 - 20 years ago
9 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
11/29/2004 - 20 years ago
8 - ASSIGNED TO LIE
Type: ALIE
-
11/21/2004 - 20 years ago
7 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
8/30/2004 - 20 years ago
6 - AMENDMENT FROM APPLICANT ENTERED
Type: ACEC
-
8/5/2004 - 20 years ago
5 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
8/5/2004 - 20 years ago
4 - Sec. 1(B) CLAIM DELETED
Type: 1.BD
-
8/5/2004 - 20 years ago
3 - PAPER RECEIVED
Type: MAIL
-
2/3/2004 - 20 years ago
2 - NON-FINAL ACTION MAILED
Type: CNRT
-
1/24/2004 - 21 years ago
1 - ASSIGNED TO EXAMINER
Type: DOCK